Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
about
Chemical Variations on the p53 Reactivation ThemeTargeting autophagy to sensitive glioma to temozolomide treatmentIdentifying Driver Genomic Alterations in Cancers by Searching Minimum-Weight, Mutually Exclusive SetsNew small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and deathInferring network structure in non-normal and mixed discrete-continuous genomic data.The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastomaPreclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type GlioblastomasLong lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage.Glioblastoma targeted therapy: updated approaches from recent biological insights.α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects.The Citrus Flavanone Naringenin Produces Cardioprotective Effects in Hearts from 1 Year Old Rat, through Activation of mitoBK Channels.TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.p53 functional inhibitors behaving like pifithrin-β counteract the Alzheimer peptide non-β-amyloid component effects in human SH-SY5Y cells.Evaluation of JC and Cytomegalo Viruses in Glioblastoma TissueApoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications.Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.Re-expression of the p53 Gene by Inhibiting the Mdm-2 Receptor in Wild-type p53 Tumors for the Treatment of Glioblastoma: A Mini Review
P2860
Q26749008-043F75C9-F50F-4C9E-BB22-27DDFFCF4BA6Q28066270-48DB5E4D-6F06-48D3-AC6C-44B943DECA84Q28608346-508C1C07-3867-483F-A784-F340755F8A19Q35448347-C1AD2E8B-DBEF-4A25-A6D6-36D99CB34F3AQ35505109-CD986AED-1E1B-46BF-87D2-3D1E8F3C4E5EQ36192530-F260BE87-7375-4C4A-94C7-4A7CF62BD6D6Q36355292-54B7D207-05FA-4679-A597-F66ADF3C6336Q36692848-ACC621B1-F652-492A-8521-91F6FDC6D811Q36828178-1E6821FC-F861-4E60-BEDC-2B8698AE9898Q36946655-25CCFD72-1505-489C-82C3-2BA3EE7A9907Q37718142-6E728834-2A40-4616-B2A1-E03214D0772AQ37721081-B239C05C-76AB-428E-B869-4E61F0825272Q38597700-F5D3360C-71AE-4D06-A7C7-C857EE8D986EQ38831103-8FA9EF96-0EB3-446D-92A9-FF2B14EE3282Q38910312-AE079890-6169-4701-8E25-D9FB063F9214Q38938735-1FF04F57-9437-4388-9379-0AFB06C69A5AQ39013934-B1F6D717-D880-4F48-96C6-15433D328577Q39207811-B4DE0399-5165-49F3-8A02-870201122954Q47136308-DCC62E2D-9439-4474-87D2-654BC9E23BB7Q47798259-7ED26821-225D-4D36-BEC3-82D13DCB1AC2Q47912632-5F75CE3B-12EE-4E92-BAE7-418591C24C2AQ49240647-F77D4D67-E557-4BA3-A78F-0818E87BC0FEQ57175023-1DAABB6A-ECB5-40B6-A6B0-D620A2EC20C3
P2860
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@ast
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@en
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@nl
type
label
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@ast
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@en
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@nl
prefLabel
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@ast
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@en
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@nl
P2093
P2860
P50
P1433
P1476
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
@en
P2093
Alessia Bertamino
Barbara Costa
Carmine Del Giudice
Daniela Sorriento
Fabrizio Scatena
Isabel Gomez-Monterrey
Pamela Gabelloni
Renato Vanacore
Sara Bendinelli
Simona Daniele
P2860
P304
P356
10.1371/JOURNAL.PONE.0072281
P407
P577
2013-08-19T00:00:00Z